Evelyne M Loyer

Author PubWeight™ 33.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005 4.86
2 Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 2009 2.35
3 High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 2011 2.28
4 Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002 2.21
5 Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006 2.06
6 Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. Radiographics 2006 1.54
7 Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol 2012 1.30
8 Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol 2010 1.22
9 Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma. J Clin Oncol 2009 1.16
10 Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 2004 1.12
11 Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg 2013 1.10
12 Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease. Clin Cancer Res 2004 1.05
13 Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog 2013 0.93
14 Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? Cancer 2011 0.88
15 Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging 2007 0.86
16 Radiologic findings in taxane induced colitis. Eur J Radiol 2007 0.86
17 Planning and follow-up after ablation of hepatic tumors: imaging evaluation. Surg Oncol Clin N Am 2010 0.85
18 Diagnosis and staging of pancreatic tumors. Semin Roentgenol 2004 0.83
19 Evaluation of cancer treatment in the abdomen: Trends and advances. World J Radiol 2013 0.82
20 Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol 2013 0.80
21 CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. AJR Am J Roentgenol 2011 0.80
22 Case 177: Congenital absence of the portal vein with hepatic adenomatosis. Radiology 2012 0.79
23 Neoplasms of the liver and the bile ducts. Semin Roentgenol 2004 0.79
24 Non-size-based response criteria to preoperative chemotherapy in patients with colorectal liver metastases: the morphologic response criteria. Curr Colorectal Cancer Rep 2013 0.77
25 Transdiaphragmatic radiofrequency ablation of liver tumors. J Am Coll Surg 2004 0.76
26 Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol 2006 0.75
27 SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions. J Gastrointest Surg 2013 0.75
28 Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence. J Comput Assist Tomogr 2017 0.75
29 (18)F-FDG Uptake at the Surgical Margin after Hepatic Resection: Patterns of Uptake and Differential Diagnosis. Eur Radiol 2015 0.75